<SEC-DOCUMENT>0001019056-21-000475.txt : 20210816
<SEC-HEADER>0001019056-21-000475.hdr.sgml : 20210816
<ACCEPTANCE-DATETIME>20210816144442
ACCESSION NUMBER:		0001019056-21-000475
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20210811
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210816
DATE AS OF CHANGE:		20210816

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Modular Medical, Inc.
		CENTRAL INDEX KEY:			0001074871
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				870620495
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-49671
		FILM NUMBER:		211177034

	BUSINESS ADDRESS:	
		STREET 1:		16772 WEST BERNARDO DRIVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92127
		BUSINESS PHONE:		858-800-3500

	MAIL ADDRESS:	
		STREET 1:		16772 WEST BERNARDO DRIVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92127

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BEAR LAKE RECREATION INC
		DATE OF NAME CHANGE:	19981208
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>modular_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">



<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-size: 18pt"><B>FORM
8-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>CURRENT REPORT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>Pursuant to
Section 13 or 15(d) of the</B>&nbsp;<B>Securities Exchange Act of 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-size: 10pt">Date of report
(Date of earliest event reported):&nbsp; August 11, 2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 100%; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt; text-align: center"><FONT STYLE="font: 24pt Times New Roman, Times, Serif"><B>MODULAR
    MEDICAL, INC.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Exact
    name of registrant as specified in its charter)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 32%; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Nevada</B></FONT></TD>
    <TD STYLE="width: 2%; padding-right: 3pt; padding-left: 3pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 32%; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>000-49671</B></FONT></TD>
    <TD STYLE="width: 2%; padding-right: 3pt; padding-left: 3pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 32%; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>87-0620495</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt">(State
        or other jurisdiction</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt">of incorporation)</FONT></P></TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Commission
    File No.)</FONT></TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt">(IRS
        Employer</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt">Identification
        No.)</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; width: 48%; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>16772
    W. Bernardo Drive, San Diego, California</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 4%; padding-right: 3pt; padding-left: 3pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 48%; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>92127</B></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Address
    of principal executive offices)</FONT></TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Zip
    Code)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">


<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 20%; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>858-800-3500</B></FONT></TD>
    <TD STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-size: 10pt">(Registrant&rsquo;s
telephone number, including area code)</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 20%; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></TD>
    <TD STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-size: 10pt">(Former name
or former address, if changed since last report)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Check the appropriate
box below if the Form&nbsp;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any
of the following provisions (see General Instruction A.2. below):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Wingdings">o</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Wingdings">o</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Wingdings">o</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Wingdings">o</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">Securities registered pursuant to
Section 12(b) of the Act:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 41%; border: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Title
    of each class</FONT></TD>
    <TD STYLE="width: 20%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Trading
    symbol(s)</FONT></TD>
    <TD STYLE="width: 39%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Name
    of each exchange on which registered</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><FONT STYLE="font-size: 10pt">Indicate by check mark whether
the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &sect;230.405) or Rule
12b-2 of the Securities Exchange Act of 1934 (17 CFR &sect;240.12b-2 ).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Emerging
growth company&nbsp;&nbsp;</FONT><FONT STYLE="font: 10pt Wingdings">x</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with
any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;</FONT><FONT STYLE="font: 10pt Wingdings">o</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 4pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Item 5.02.</B></FONT></td>
    <TD STYLE="width: 90%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</B></FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I><U>Departure of Directors or Certain Officers</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Effective August 11, 2021, Paul DiPerna resigned as chief executive officer of Modular Medical, Inc. (the &ldquo;Company&rdquo;). Mr. DiPerna continues to serve as chairman of the Company&rsquo;s board of directors (the &ldquo;Board&rdquo;),  and as president, chief financial officer and secretary of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I><U>Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Effective August 11, 2021, the Board appointed Ellen O&rsquo;Connor Vos, a member of the Board since May 18, 2021, as chief executive officer of the Company.  Ms. Vos, who is 65, has served as a member of VosHealth LLC since November 2020. Prior to such time, she served as president and chief executive officer of the Muscular Dystrophy Association from October 2017 to November 2020 and chief executive officer of ghg | greyhealth group from 1996 to 2017. Ms. Vos has been a champion of using digital capabilities to improve public health. She serves on the board of OptimizeRX Corporation, a publicly-traded digital health company, and the Jed Foundation, a leading nonprofit dedicated to protecting the emotional health of college students, and was a founding board member of MMRF, a pioneering cancer research foundation. Ms. Vos holds a B.S. in nursing from Alfred University.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-size: 10pt">On August 11, 2021, the Company entered into a two year employment agreement (the &ldquo;Agreement&rdquo;) with Ms. Vos for her service as chief executive officer, which renews for one-year terms, unless either party provides the other with 90 day prior written notice of termination. The Agreement provides that Ms. Vos will be entitled to total base compensation of $300,000 annually, as follows: a cash salary of $250,000 per year (the &ldquo;Cash Salary&rdquo;), plus deferred salary of $50,000 per year (the &ldquo;Deferred Salary&rdquo; and, together with the Cash Salary, the &ldquo;Base Compensation&rdquo;).  The Deferred Salary accrues monthly, is fully vested and nonforfeitable, and is payable in full in cash upon the earliest of: (i) the last day of Ms. Vos&rsquo; employment with the Company or (ii) a &ldquo;change of control,&rdquo; as defined and determined in accordance with the Agreement.  Notwithstanding the foregoing, upon occurrence of a change of control, or the registration of the Company&rsquo;s common stock on a national or international stock exchange, Ms. Vos&rsquo; Cash Salary shall be increased to at least $300,000 and no portion thereof shall be deferred. Ms. Vos will also be eligible to receive an annual performance bonus of $300,000, upon achievement of certain agreed upon goals, as determined by Ms. Vos and the Board, and will be reimbursed by the Company for up to $30,000 per year for travel and temporary living expenses in San Diego County, California.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Pursuant to the Agreement, the Company granted Ms. Vos an option to purchase 1,087,354 shares (&ldquo;Option Shares&rdquo;) of the Company&rsquo;s common stock (the &ldquo;Option&rdquo;), at an exercise price of $4.06 per share, the closing price of the Company&rsquo;s common stock on the OTCQB Market on August 10, 2021.  Twenty percent of the Option Shares vest after six months with the remaining Option Shares vesting in equal monthly amounts over the next 42 months.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Except for a termination for &ldquo;cause,&rdquo; in the event of Ms. Vos&rsquo; termination by the Company without cause or Ms. Vos&rsquo; termination for &ldquo;good reason&rdquo; within six months before or 12 months after a change of control, Ms. Vos shall be entitled to a lump sum cash severance payment equal to: i) two times Ms. Vos&rsquo; then-current Base Compensation, ii) any Base Compensation and bonus earned but not already paid; iii) reimbursement for 12 months for the continuation of healthcare insurance coverage; and iv) accelerated vesting of all unvested Option Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Pursuant to the Agreement, Ms. Vos is subject to certain restrictions relating to Company confidential information, employees, customers and suppliers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Since the beginning of the Company&rsquo;s last fiscal year through the present, there have been no transactions with the Company, and there are currently no proposed transactions with the Company, in which the amount involved exceeds $120,000, and in which Ms. Vos had, or will have, a direct or indirect material interest within the meaning of Item 404(a) of Regulation S-K.  No arrangement or understanding exists between Ms. Vos and any other person pursuant to which Ms. Vos was appointed an officer of the Company.</FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Item 8.01.</B></FONT></td>
    <TD STYLE="width: 90%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Other Events.</B></FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I><U>Other</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-size: 10pt">On August 16, 2021, the Company issued a press release announcing the appointment of Ms. Vos as the Company&rsquo;s chief executive officer, as described in Item 5.02 above.  A copy of the press release is furnished as Exhibit 99.1 hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Item 9.01.</B></FONT></td>
    <TD STYLE="width: 90%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Financial Statements and
    Exhibits.</B></FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(d)</FONT></td>
    <TD STYLE="width: 90%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Exhibits:</FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B><U>Exhibit No.</U></B></FONT></td>
    <TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></td>
    <TD STYLE="width: 89%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B><U>Description</U></B></FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">10.27</FONT></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="ex10_27.htm"><FONT STYLE="font-size: 10pt">Employment Agreement between the Company and Ellen O&rsquo;Connor Vos dated August 11, 2021</FONT></A></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">99.1</FONT></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="ex99_1.htm"><FONT STYLE="font-size: 10pt">Press Release by Modular Medical, Inc. dated August 16, 2021</FONT></A></td></tr>
</table>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 60%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Modular
    Medical, Inc.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Date:
    August 16, 2021</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">/s/
    Paul DiPerna</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><FONT STYLE="font-size: 10pt">President,
                                                         Chief Financial Officer, </FONT><BR> <FONT STYLE="font-size: 10pt">Secretary and
                                                         Treasurer</FONT></P></TD></TR>
</TABLE>

    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.27
<SEQUENCE>2
<FILENAME>ex10_27.htm
<DESCRIPTION>EXHIBIT 10.27
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">


<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-size: 10pt"><B>Exhibit 10.27</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>EMPLOYMENT AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">THIS
EMPLOYMENT AGREEMENT (the &ldquo;Agreement&rdquo;) is made and effective as of August 11, 2021, between Modular Medical, Inc.,
a Nevada corporation (the &ldquo;Company&rdquo;), and Ellen (Lynn) O&rsquo;Connor Vos (&ldquo;Executive&rdquo;) (each a &ldquo;Party&rdquo;
and collectively the &ldquo;Parties&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">WHEREAS,
Executive has been retained as a Board Member of Company since on or about May 2021; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">WHEREAS,
the Parties hereto deem it to be in their best interests to formalize their relationship and to enter into an employment agreement
whereby the Company will employ Executive pursuant to the terms and conditions set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">NOW,
THEREFORE, in consideration of the premises and mutual covenants herein contained, the receipt and sufficiency of which the Parties
hereby acknowledge, the Parties agree as follows:</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt (normal text),serif">1.</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Employment</U>.
Upon the terms and subject to the conditions contained in this Agreement, the Company hereby employs Executive as the Chief Executive
Officer of the Company, with responsibility for overseeing and directing all operations of the Company, subject to the authority
and directives of the Company&rsquo;s Board of Directors (the &ldquo;Board&rdquo;). Executive shall diligently and conscientiously
devote her substantial time and attention to the discharge of her duties as Chief Executive Officer. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">1.1<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Other
Business Activities</U>. Executive has disclosed to Company and Company acknowledges that Executive is currently involved in the
other business activities described on Schedule 1.1 hereto (the &ldquo;Disclosed Activities&rdquo;). Company has determined
that the Disclosed Activities do not currently conflict with the Company&rsquo;s business plans or strategies, and Executive shall
be permitted to continue to engage in the Disclosed Activities for the Term of this Agreement (as defined below); provided, however,
that the Board and Executive agree to periodically mutually review the Disclosed Activities and assess the impact, if any, of
such activities on Executive&rsquo;s duties pursuant to this Agreement. Nothing in this Agreement shall prohibit Executive from
serving as a director of or investor in other business enterprises or non-profit entities so long as such activities do not materially
conflict with Executive&rsquo;s duties hereunder. Executive has disclosed, and the Company expressly permits, her continued service
as a consultant for Hill &amp; Knowlton through the completion of the current project.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Term</U>.
Subject to the severance provisions of Section 5 below, Executive&rsquo;s employment with the Company shall initially be for a
term of two (2) years beginning August 11, 2021 and ending August 10, 2023 (&ldquo;Initial Term&rdquo;) and shall thereafter automatically
renew for one-year terms unless either party terminates the Agreement with 90 days prior written notice of termination before
the end of the then current term (each additional one-year term a &ldquo;Renewal Term&rdquo; and the Initial Term with any Renewal
Term[s] being collectively referred to herein as the &ldquo;Term&rdquo;). Executive will be given 90 days written notice if the
Board plans not to renew the Term.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Compensation</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Base
Compensation</U>. Executive shall be entitled to total base compensation of $300,000.00 annually, as follows: Executive shall
receive a cash salary of $250,000.00 per year ($20,833.33 per month) (the &ldquo;Cash Salary&rdquo;), plus deferred salary of
$50,000.00 per year (the &ldquo;Deferred Salary&rdquo; and together with the Cash Salary, Executive&rsquo;s &ldquo;Base Compensation&rdquo;).
The Deferred Salary shall accrue monthly, shall be fully vested and nonforfeitable, and shall be payable in full in cash upon
the earliest of (i) the last day of Executive&rsquo;s employment by the Company or (ii) a Change of Control, as determined under
Section 6. The Cash Salary shall be payable less applicable deductions and withholding in normal installments and in accordance
with the payroll practices of Company. Payment of the Deferred Salary shall be subject to applicable withholdings. Executive&rsquo;s
Base Compensation shall not be reduced without agreement of Executive. Notwithstanding the foregoing, upon the occurrence of a
Change of Control or the registration of the Company&rsquo;s shares on a national or international stock exchange, Executive&rsquo;s
Cash Salary shall be increased to at least $300,000 and no portion thereof shall be deferred.</FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Bonus</U>.
In addition to her Base Compensation, Executive shall receive an annual cash bonus with a target of $300,000.00 upon achievement
of certain agreed upon goals as determined by Executive and the Company&rsquo;s Board, which shall be deemed earned compensation
as of December 31 of the calendar year to which the bonus applies. The bonus shall be payable upon the filing of the Company&rsquo;s
annual form 10-K with the U.S. Securities and Exchange Commission for the year earned but in no event later than December 31 of
the year following the year for which the bonus is earned. At the Company&rsquo;s option, up to one-half of the bonus may be paid
in shares of the Company&rsquo;s common stock, which shall be fully vested. Payment of the bonus shall be subject to applicable
withholdings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock
Options</U>. In addition to her Base Compensation, effective as of the Effective Date, Company shall grant Executive an option
(the &ldquo;Option&rdquo;) to purchase up to a total of 1,087,354 shares of the Company&rsquo;s common stock, at an exercise price
equal to the fair market value of the shares as of the date of grant. Twenty percent (20%) of the Option shall vest after six
months, and the remaining eighty percent (80%) of such shares shall become vested in equal monthly installments over the next
forty-two (42) months on the corresponding day of each month. The foregoing notwithstanding, any unvested portion of the Option
shall become fully vested upon a Change of Control. The Option shall be subject to such terms and conditions (including, without
limitation, provisions in the Option award agreement relating to method of exercise and payment, withholding, adjustments in the
case of changes in capital structure, nontransferability and rights of repurchase and first refusal) not inconsistent with the
foregoing and in accordance with the Company&rsquo;s 2017 Equity Incentive Plan (the &ldquo;Plan&rdquo;), as may be determined
by the Company&rsquo;s Board in its sole discretion; provided, however, that Executive shall have not less than 30 days after
termination of employment in which to exercise any options provided by the Option and provided, further, that Executive shall
be entitled to elect to have shares withheld to satisfy the statutory minimum tax withholding obligations. The general terms and
conditions of the Option shall be set forth in an agreement between the Company and Executive incorporating the provisions herein
and such agreement shall evidence such grants. For the avoidance of doubt, the Option for 1,087,354 shares provided for herein
is in addition to the options to purchase up to 50,000 shares previously awarded to Executive as a member of the Board (the &ldquo;Director&rsquo;s
Option&rdquo;). The 1,137,354 total shares subject to the Option and the Director&rsquo;s Option is equal to five percent (5%)
of the outstanding shares of common stock of the Company plus employee stock options as of the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Benefits</U>.
During the period of employment, the Company shall provide Executive with such employee benefits as are provided by the Company
generally to its executive employees. In addition, Company shall provide Executive at Company&rsquo;s expense, or shall reimburse
Executive, for appropriate telecommunications and internet service and devices as needed for Executive to perform her duties pursuant
to this Agreement. Executive shall receive four (4) weeks of paid vacation days per calendar year, which may be taken, in Executive&rsquo;s
discretion, subject to the reasonable needs of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Reimbursement
of Expenses</U>. The Company shall reimburse Executive for all reasonable and necessary expenses incurred by her in connection
with her employment and in accordance with Company policy, which requires reasonable evidence of expenditure. In addition, Company
shall reimburse Executive for travel and temporary living expenses in San Diego County up to $30,000.00 per year during the Term
of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.05in 0 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">4.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Insurance
and Indemnification Agreement</U>. The Company shall provide insurance coverage for Executive, as set forth below, in a reasonable
amount to cover reasonable risks associated with her position and shall further indemnify, defend and hold Executive harmless
from all liability in connection with her employment, excepting only liability arising out of those acts which would exclude her
from coverage under the Company&rsquo;s Directors and Officers (&ldquo;D&amp;O&rdquo;) insurance policy. Executive and Company
have previously entered into an Indemnity Agreement whereby Company agrees to indemnify Executive on the terms as set forth therein.
In addition, Company shall obtain a D&amp;O policy covering all officers and directors of the Company, including Executive, with
coverage as determined by the Board of Directors.</FONT></P>
<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0; text-align: justify; text-indent: 1in">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination of Employment</U>.
Executive and the Company acknowledge and agree that either party may terminate Executive&rsquo;s employment at any time, for any reason
or no reason, upon ninety (90) days written notice to the other party; provided, that the Company in its sole discretion may determine
that Executive&rsquo;s last day of work is either the date that Executive provides notice of the termination, or the date Company
provides notice of termination, or on the date that is 90 days from the date of the notice of termination (the 90 day period from
the notice being referred to as the &ldquo;Notice Period&rdquo;), or at any time during the Notice Period, but the effective date
of any such termination shall be the last day of the Notice Period and in any event Executive shall be considered an employee
through the last day of the Notice Period and therefore shall continue to receive all compensation and benefits to which she is
entitled as an active employee; provided further, that a termination by the Company for Cause shall be effective immediately unless
set forth otherwise in writing as determined by Company. Any termination shall be subject to the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: justify; text-indent: 1.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Certain Definitions</U>.
As used herein, the following terms shall have the following definitions:</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: justify; text-indent: 2in"><FONT STYLE="font-size: 10pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Good
Reason</U>. For purposes of this Agreement, &ldquo;Good Reason&rdquo; means: (A) a material reduction or adverse change in Executive&rsquo;s
title, position, duties or compensation without Executive&rsquo;s prior express written consent; (B) any change in reporting responsibilities
other than to the Chairperson of the Company&rsquo;s Board, (C) a relocation of Executive&rsquo;s principal place of employment
to a location more than thirty (30) miles from her then current location, other than requiring up to 40% of Executive&rsquo;s
working time in the Company&rsquo;s San Diego office, (D) the Company&rsquo;s assignment of its rights hereunder to any subsidiary
or affiliate of the Company or a successor to all or substantially all of the Company&rsquo;s business as part of a merger with, or
acquisition of the Company by, another business entity, without Executive&rsquo;s consent or (E) any other material breach by
the Company of its obligations hereunder, which breach remains uncured for thirty (30) days following written notice to the Company
of such breach, which notice specifies in reasonable detail the nature of such breach.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 2in"><FONT STYLE="font-size: 10pt">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Disability</U>.
For purposes of this Agreement &ldquo;Disability&rdquo; shall mean Executive&rsquo;s complete inability to perform her duties
as determined by the Executive&rsquo;s physician, which inability continues for more than one hundred eighty (180) consecutive
days; provided, however, that in the event any disability income policy maintained by the Company contains a definition of &ldquo;permanent
disability&rdquo; which requires a greater period of continuous inability to perform services, such definition shall control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 2in"><FONT STYLE="font-size: 10pt">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Cause</U>.
For the purposes of this Agreement, Cause shall mean: (i)&nbsp;Executive&rsquo;s conviction of a felony or similar crime causing material
harm to the standing and reputation of the Company; (ii) Executive&rsquo;s dishonesty or fraud that causes material economic harm
to the Company; (iii) Executive&rsquo;s gross fiscal or fiduciary malfeasance. With respect to the above, if such basis for Cause
is capable of cure, the Company shall give Executive written notice describing the issue and why it constitutes Cause and allow
Executive a reasonable opportunity to remedy the situation, and only if Executive fails to cure shall there exist Cause.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: justify; text-indent: 1.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Voluntary Termination</U>.
Executive may resign or otherwise terminate her employment at any time as set forth in Section 5 above. Any such resignation by
Executive other than a resignation for Good Reason shall be a Voluntary Termination. Upon a Voluntary Termination, the Company
shall pay Executive (i) her Base Compensation (including credit for Deferred Salary) through the period ending on the effective
date of termination and (ii) all unpaid Deferred Salary earned through the last day of employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: justify; text-indent: 1.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Severance</U>. Company shall
pay Executive a &ldquo;Severance Payment&rdquo; as set forth in the following circumstances:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: justify; text-indent: 2in"><FONT STYLE="font-size: 10pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Non-Renewal
of the Initial Term or any Renewal Term</U>. The Company&rsquo;s failure to renew the Initial Term shall be treated as a termination
without Cause as set forth in section (ii) below. The Company&rsquo;s failure to renew any Renewal Term shall result in Executive&rsquo;s
entitlement to (A) any Base Compensation earned through the last date of employment, (B) all unpaid Deferred Salary earned through the
last day of employment, and (C) any unpaid bonus.</FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 2in"><FONT STYLE="font-size: 10pt">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination
by the Company Without Cause or by Executive With Good Reason other than in conjunction with a Change of Control</U>. Except for
a termination in conjunction with a Change of Control as set forth in Section 5(c)(v) below, if the Company terminates Executive&rsquo;s
employment without Cause, or Executive resigns with Good Reason, then Company shall Pay Executive (A) a lump sum cash Severance
Payment equal to the Executive&rsquo;s annual Base Compensation, (B) any awarded but unpaid cash bonus, (C) all unpaid Deferred
Salary earned through the last day of employment; and (D) reimbursement for 12 months of the continuation of healthcare coverage
pursuant to COBRA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.9in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 2in"><FONT STYLE="font-size: 10pt">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination With Cause</U>. In the event of a termination for Cause, the Company shall not be obligated to make any Severance
Payment to Executive. Executive will be paid Base Compensation through the last day of employment, and all unpaid Deferred Salary
earned through the last day of employment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 2in"><FONT STYLE="font-size: 10pt">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination
Due to Death/Disability</U>. In the event of termination due to death or Disability, Executive or her legal representative shall
be entitled to (A) any Base Compensation earned through the last date of employment, (B) all unpaid Deferred Salary earned through
the last day of employment, and (C) any unpaid bonus. In addition, Executive will remain eligible for all applicable benefits
relative to death or Disability pursuant to the plans and policies, if any, in place at the time. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 2in"><FONT STYLE="font-size: 10pt">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Change of Control</U>. Except for a termination for Cause, in the event of Executive&rsquo;s termination by the Company Without
Cause or Executive&rsquo;s termination for Good Reason within six months before or 12 months after a Change of Control, as determined
under Section 6(a), <FONT STYLE="font-family: -webkit-standard,serif"><I> </I>and </FONT>in lieu of any other Severance Payment
which may otherwise be due under Section 5(c),<FONT STYLE="font-family: -webkit-standard,serif"> </FONT>Executive shall be paid
a lump sum cash Severance Payment equal to (A) two (2) times Executive&rsquo;s then-current Base Compensation, (B) any Base Compensation
and bonus earned but not already paid; and (D) reimbursement for 12 months for the continuation of healthcare coverage whether
or not pursuant to COBRA. Any Options not already vested shall be fully vested. If the Company has repurchased any shares acquired
by the Executive (whether or not pursuant to the Option Award) within six months before a Change of Control (or if she otherwise
has been paid the value of such shares in connection with her termination of employment), the Company shall make an additional
payment to her equal to any difference (but not less than zero) between the price paid for Executive&rsquo;s shares and the value
of the transaction consideration in the Change of Control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Change of Control</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Definition</U>.
For purposes of this Agreement, &ldquo;Change of Control&rdquo; means the removal of Executive as Chief Executive Officer as the
result of the occurrence of any of the following events: (A) the sale, lease, conveyance or other disposition of all or substantially
all of the Company&rsquo;s assets as an entirety or substantially as an entirety to any person, entity or group of persons acting
in concert; (B) any &ldquo;person&rdquo; (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934,
as amended), other than any then-currently existing shareholder as of the Change of Control date, becoming the &ldquo;beneficial
owner&rdquo; (as defined in Rule 13d-3 under said act), directly or indirectly, of securities of the Company representing fifty
percent (50%) or more of the total voting power represented by the Company&rsquo;s then-outstanding voting securities but in no
event shall the completion of an offering (i) of the Company&rsquo;s Common Stock pursuant to a registration statement filed with
the Securities and Exchange Commission in the Company&rsquo;s initial public offering; or (ii) a private offering of shares of
the capital stock of the Company constitute a Change of Control; or (C) a merger or consolidation of the Company with any other
corporation or entity not affiliated with any currently existing shareholder, other than a merger or consolidation which would
result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining
outstanding or by being converted into voting securities of the surviving entity) at least fifty percent (50%) of the total voting
power represented by the voting securities of the Company or such surviving entity outstanding immediately after such merger or
consolidation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1.5in; text-align: justify"><FONT STYLE="font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Acceleration
of Options, Vesting</U>. The Option granted in Section 3(c) herein shall become fully vested and immediately exercisable with
respect to all of the shares subject to the Option upon the occurrence of a Change of Control.</FONT></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Confidential
Information; <U>Non-Hire; Non-Solicitation</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font: 10pt (normal text),serif">(a)</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Confidential
Information</U>. Executive recognizes and acknowledges the competitive and proprietary aspects of the business of the Company,
and that as a result of Executive&rsquo;s employment, Executive recognizes and acknowledges that Executive has had and will continue
to have access to, and has been and will continue to be involved in the development of, Confidential Information (as defined below)
of the Company. As used herein, &ldquo;Confidential Information&rdquo; shall mean and include trade secrets, knowledge and other
confidential information of the Company, which Executive has acquired, no matter from whom or on what matter such knowledge or
information may have been acquired, heretofore or hereafter, concerning the content and details of the business of the Company,
and which is not known to the general public, including but not limited to: confidential and proprietary information supplied
to Executive with the legend &ldquo;Confidential and Proprietary,&rdquo; or equivalent, the Company&rsquo;s marketing and customer
support strategies, suppliers and customers, marketing and selling, business plans, licenses, the Company&rsquo;s financial information,
including sales, costs, profits, prices, pricing methods, budgets and unpublished financial statements, the Company&rsquo;s internal
organization, employee information obtained pursuant to Executive&rsquo;s duties and responsibilities, information regarding the
skills and compensation of other employees of the Company obtained pursuant to Executive&rsquo;s duties and responsibilities and
customer lists, the Company&rsquo;s technology, including products, discoveries, inventions, research, experimental and development
efforts, clinical studies, processes, hardware/software design and maintenance tools, samples, media and/or molecular structures
(and procedures and formulations for producing any such samples, media and/or molecular structures), formulas, methods, know-how
and show-how, designs, prototypes, plans for research and new products, and all derivatives, improvements and enhancements of
any of the above and information of third parties as to which the Company has an obligation of confidentiality.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 2in"><FONT STYLE="font: 10pt (normal text),serif">(i)</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">For
as long as Executive is employed and at all times thereafter, Executive shall not, directly or indirectly, communicate, disclose
or divulge to any person or entity, or use for Executive&rsquo;s own benefit or the benefit of any person (other than the Company),
any Confidential Information, except as permitted in subparagraph (iii) below. Upon termination of Executive&rsquo;s employment,
or at any other time at the request of the Company, Executive agrees to deliver promptly to the Company all Confidential Information,
including, but not limited to, customer and supplier lists, files and records, in Executive&rsquo;s possession or under Executive&rsquo;s
control. Executive further agrees that Executive will not make or retain any copies of any of the foregoing and will so represent
to the Company upon termination of Executive&rsquo;s employment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 2in"><FONT STYLE="font: 10pt (normal text),serif">(ii)</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Executive
shall disclose immediately to the Company any trade secrets or other Confidential Information conceived or developed by Executive
at any time during Executive&rsquo;s employment. Executive hereby assigns and agrees to assign to the Company Executive&rsquo;s
entire right, title and interest in and to all Confidential Information. Such assignment shall include, without limitation, the
rights to obtain patent or copyright protection thereon in the United States and foreign countries. Executive agrees to provide
all reasonable assistance to enable the Company to prepare and prosecute any application before any governmental agency for patent
or copyright protection or any similar application with respect to any Confidential Information. Executive further agrees to execute
all documents and assignments and to make all oaths necessary to vest ownership of such intellectual property rights in the Company,
as the Company may request. These obligations shall apply whether or not the subject thereof was conceived or developed at the
suggestion of the Company, and whether or not developed during regular hours of work or while on the premises of the Company.</FONT></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 2in"><FONT STYLE="font: 10pt (normal text),serif">(iii)</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Except
as set forth below, Executive shall at all times, both during and after termination of this Agreement by either Executive or the
Company, maintain in confidence and shall not, without prior written consent of the Company, use, except in the course of performance
of Executive&rsquo;s duties for the Company or as required by legal process (provided that Executive will promptly notify the
Company of such legal process except with respect to any confidential government investigation), disclose or give to others any
Confidential Information. In the event Executive is questioned by anyone not employed by the Company or by an employee of or a
consultant to the Company not authorized to receive such information, in regard to any such information or any other secret or
confidential work of the Company, or concerning any fact or circumstance relating thereto, Executive will promptly notify the
Company. Notwithstanding the foregoing, however, nothing in this Agreement or elsewhere prohibits Executive from communicating
with government agencies about possible violations of federal, state, or local laws or otherwise providing information to government
agencies, filing a complaint with government agencies, or participating in government agency investigations or proceedings. Executive
is not required to notify the Company of any such communications; provided, however, that nothing herein authorizes the disclosure
of information Executive obtained through a communication that was subject to the attorney-client privilege. Further, notwithstanding
Executive&rsquo;s confidentiality and nondisclosure obligations, Executive is hereby advised as follows pursuant to the Defend
Trade Secrets Act: &ldquo;An individual shall not be held criminally or civilly liable under any Federal or State trade secret
law for the disclosure of a trade secret that (A) is made (i) in confidence to a Federal, State, or local government official,
either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation
of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.
An individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade
secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual (A) files
any document containing the trade secret under seal; and (B) does not disclose the trade secret, except pursuant to court order.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font: 10pt (normal text),serif">(b)</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">During
the Term and for a one-year period commencing at the end of the Term and/or on the effective date of any termination in accordance
with Section 5 or Section 6 if before the end of the Term, Executive covenants and agrees as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 2in"><FONT STYLE="font-size: 10pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Non-hire/non-solicitation
of employees</U>. Executive shall not hire any officer, director, executive or employee of the Company who is employed or otherwise
engaged by the Company or has been employed or otherwise engaged by the Company during the previous 6 months, nor shall Executive
solicit or attempt to solicit any such person to leave his or her employment or engagement with the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 2in"><FONT STYLE="font-size: 10pt">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Customer
non-interference/non-solicitation</U>. Executive shall not, directly, or indirectly, interfere with any contract, relationship,
potential contract or potential relationship between the Company and any customer, client, business or potential customer, client
or business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 2in"><FONT STYLE="font-size: 10pt"><B></B>(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Non-
solicitation of suppliers</U>. Executive also agrees and covenants that she shall not divert or attempt to divert from the Company,
any Company supplier or vendor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Other
Agreements</U>. Executive represents and warrants that the execution and delivery of this Agreement and the performance of all
the terms of this Agreement do not and will not breach any agreement to keep in confidence proprietary information acquired by
Executive in confidence or trust. Executive has not entered into and shall not enter into any agreement, either written or oral,
in conflict with this Agreement. Executive represents that she has not brought and will not bring with her to the Company or use
at the Company any materials or documents of an employer or a former employer that are not generally available to the public unless
express written authorization from such employer for their possession and use has been obtained. Executive further understands
that she is not to breach any obligation of confidentiality that she has to any employer or former employer and agrees to fulfill
all such obligations during the period of her affiliation with the Company.</FONT></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>.
All notices or other communications which are required or permitted hereunder shall be in writing and sufficient if (a) delivered
personally or sent by telecopier, (b) sent by nationally-recognized overnight courier or (c) sent by certified mail, postage prepaid,
return receipt requested, addressed as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">if
to the Company, to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0"><FONT STYLE="font-size: 10pt">Modular
Medical, Inc.</FONT><BR>
<FONT STYLE="font-size: 10pt">16772 W. Bernardo Drive</FONT><BR>
<FONT STYLE="font-size: 10pt">San Diego, CA 92127</FONT><BR>
<FONT STYLE="font-size: 10pt">Attention: Chief Financial Officer</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: justify"><FONT STYLE="font-size: 10pt">and
if to Executive, to Executive&rsquo;s address on the books or records of the Company, or to such other address as the Party to whom
notice is to be given may have furnished to each other Party in writing in accordance herewith. Any such communication shall be
deemed to have been given (i) when delivered if personally delivered or sent by facsimile transmission, (ii) on the Business Day
(as hereinafter defined) after dispatch if sent by nationally-recognized, overnight courier and (iii)&nbsp;on the fifth Business
Day after dispatch if sent by first class U.S. mail. As used herein, &ldquo;Business Day&rdquo; means a day that is not a Saturday,
Sunday or a day on which banking institutions in California are not required to be open.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Entire
Agreement; Amendments</U>. This Agreement contains the entire agreement between the parties with respect to the subject matter
hereof and supersedes all prior or contemporaneous negotiations, correspondence, understandings and agreements between the parties
with respect thereto. This Agreement may be amended only by an agreement in writing signed by both parties hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.1in 0 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Assignment Successors: Benefits
of Agreement</U>. This Agreement is personal in its nature and neither Party hereto shall, without the consent of the other, assign
or transfer this Agreement or any rights or obligations hereunder; provided, however, that the Company shall have the right to
assign its rights hereunder to any subsidiary or affiliate of the Company or a successor to all or substantially all of the Company&rsquo;s
business as part of a merger with, or acquisition of the Company by, another business entity, but if the Company does not obtain
Executive&rsquo;s consent then such shall be deemed Good Reason as defined above. The provisions of this Agreement shall be binding
upon and inure to the benefit of, as applicable, the respective heirs, executors, administrators and successors and permitted
assigns of the parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Waiver of Breach</U>. A waiver of
any breach of any provision of this Agreement shall not constitute or operate as a waiver of any other breach of such provision
or of any other provision, and any failure to enforce any provision hereof shall not operate as a waiver of such provision or
of any other provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Counterparts:
Headings</U>. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of
which shall constitute one and the same instrument. Headings said herein are for convenience of reference only and are not to
affect the interpretation of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing
Law</U>. This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of California.</FONT></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Severability</U>.
In the event that any provision of this Agreement would be held in any jurisdiction to be invalid, prohibited or unenforceable
for any reason, such provision, as to such jurisdiction, shall be ineffective, without invalidating the remaining provisions of
this Agreement or affecting the validity or enforceability of such provision in any other jurisdiction. Notwithstanding the foregoing,
if such provision could be more narrowly drawn so as not to be invalid, prohibited or unenforceable in such jurisdiction, it shall,
as to such jurisdiction, be so narrowly drawn, without invalidating the remaining provisions of this Agreement or affecting the
validity or enforceability of such provision in any other jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Remedies</U>.
Executive acknowledges and understands that the provisions of this Agreement are of a special and unique nature, the loss of which
cannot be adequately compensated for in damages by an action at law, and that the breach or threatened breach of the provisions
of this Agreement would cause the Company irreparable harm. In the event of a breach or threatened breach by Executive of the
provisions of this Agreement, the Company shall be entitled to apply for an injunction restraining her from such breach.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">IN WITNESS WHEREOF,
the parties have duly executed this Agreement as of the date first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>EXECUTIVE</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>COMPANY</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 3%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 47%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 3%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 47%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>MODULAR MEDICAL, INC., a</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Nevada corporation</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><U>/s/ Lynn Vos&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">By:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><U>/s/ Paul M. DiPerna</U></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Ellen (Lynn) O&rsquo;Connor
    Vos</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Paul M. DiPerna,</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">President</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>







    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ex99_1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">



<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><IMG SRC="ex99_1.jpg" ALT="(LOGO)"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>MODULAR MEDICAL
EXPANDS EXECUTIVE TEAM WITH APPOINTMENT OF </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>LYNN O&rsquo;CONNOR
VOS AS NEW CEO </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><I>O&rsquo;Connor
Vos Brings Deep Experience in Market Development,</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><I>Commercializing
Products and Patient Advocacy</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">SAN DIEGO, CA
/ ACCESSWIRE /August 16, 2021 / Modular Medical, Inc. (OTCQB:MODD), a development-stage insulin pump company focused on providing
insulin delivery without complexity to increase pump adoption and reduce the burden of diabetes care for clinicians and individuals
living with diabetes, today announced the expansion of its executive team with the appointment of Lynn O&rsquo;Connor Vos as its
new Chief Executive Officer.<FONT STYLE="background-color: white"> </FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt; background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt; background-color: white">The
company&rsquo;s founder, industry veteran and renowned diabetes medical innovator, Paul DiPerna, will take on the role of Chairman,
President and Chief Technology Officer while continuing to drive platform development and R&amp;D efforts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">In her new role as CEO, O&rsquo;Connor
Vos <FONT STYLE="background-color: white">will look to accelerate the company&rsquo;s effort to bring affordable insulin delivery
for </FONT>greater adoption in the market by providing more<FONT STYLE="background-color: white"> individuals the opportunity
to achieve better diabetes health outcomes. In addition, she will focus on driving Modular Medical&rsquo;s initiatives for </FONT>public/private/commercial
<FONT STYLE="background-color: white">partnerships and advocacy, refining the patient experience and addressing the needs of </FONT>the
3.5 million Americans who require intensive insulin therapy today. &nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Before joining
Modular Medical, O&rsquo;Connor Vos served as the President and CEO of the Muscular Dystrophy Association (&ldquo;MDA&rdquo;)
for three years. She was instrumental in relaunching the organization&rsquo;s focus on innovations in science and care and successfully
built a pharmaceutical partnership practice. Prior, O&rsquo;Connor Vos was a founding executive and CEO at Grey Healthcare Group,
a WPP-owned global healthcare communications firm serving a full range of pharma, biotech, surgical, diabetes, and diagnostic
companies with extensive work on healthcare launches. At WPP, she helped grow the agency from an independent domestic professional
firm into a top 10 award-winning global enterprise with fully integrated, multi-channel offerings. During her tenure, she led
the selection, evaluation, and negotiation of key deals to establish new digital, patient access and specialty care capabilities.
Additionally, O&rsquo;Connor Vos has experience driving significant product launches and public-private partnerships for multiple
healthcare companies, including Text4Baby, a highly recognized national women&rsquo;s mobile health program.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&ldquo;Lynn is
a global healthcare business leader, with a broad range of omnichannel experience and an established launch track record that
will help Modular Medical as we continue to prepare for the commercial launch of our initial product in 2022,&rdquo; commented
DiPerna. &ldquo;Additionally, Lynn&rsquo;s deep experience in tackling important healthcare challenges and establishing compelling
programs to address significant unmet needs will further help our company as we bring our novel approach of insulin delivery to
the market and outcomes for people living with diabetes.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Modular Medical
is committed to making insulin pump technology a cornerstone of better control for all people living with diabetes, with a particular
focus on historically underserved communities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&ldquo;I&rsquo;m
extremely pleased and excited to join Modular Medical at this pivotal point of its development and commercialization efforts.
I look forward to working with the Modular Medical team in addressing areas of improving diabetes care by tackling the most significant
barriers: access and affordability, and making it easier for clinicians, caregivers and individuals to manage diabetes care,&rdquo;
said O&rsquo;Connor Vos. &ldquo;I&rsquo;m looking forward to engaging with the diabetes community again, after started my career
working on diabetes care programs, and believe there are meaningful opportunities to utilize innovative technology and therapies
like Modular Medical&rsquo;s to improve the consumer experience and health outcomes.&rdquo;</FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><IMG SRC="ex99_1.jpg" ALT="(LOGO)"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>About Modular Medical,
Inc</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Modular Medical,
Inc. (OTCQB:MODD) is a development-stage diabetes technology company based in San Diego CA. Working from an innovative set of
patented technologies, Modular seeks to expand access to high end diabetes technologies to the heretofore neglected majority of
the diabetes market who have been poorly served by the existing options which have been too expensive and complex to drive broad
adoption. Our strategy is to provide care at a level of cost and complexity designed not for &ldquo;superusers&rdquo; but for &ldquo;the
rest of us&rdquo;. Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and world-class microfluidics
engineer. Mr. DiPerna was previously the founder (in 2005) of Tandem Diabetes (TNDM) and invented and designed their T:slim insulin
pump.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><FONT STYLE="font-size: 10pt">More information
is available at&nbsp;<U>https://modular-medical.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Forward Looking
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">This press release
contains forward-looking statements regarding the expected timing of commercialization of the company&rsquo;s initial product.
Forward-looking statements are based on certain assumptions and expectations of future events that are subject to risks and uncertainties.
Actual results and trends may differ materially from those projected in any such forward-looking statements depending on a variety
of factors, including market conditions, the company&rsquo;s ability to commence commercialization of its initial product in a timely
fashion, and other risks identified in the company&rsquo;s most recent reports on Form 10-Q and Form 10-K filed with the SEC, as well
as other reports that Modular Medical files from time to time with the SEC. Modular Medical undertakes no obligation to update
publicly any forward-looking statement for any reason, except as required by law, even as new information becomes available or
other events occur in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">All trademarks
mentioned herein are the property of their respective owners.<B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Media Contact</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Lori Robinson</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">MWW</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><U>lrobinson@mww.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Investor Relations Contact</B></FONT><BR>
<FONT STYLE="font-size: 10pt">Modular Medical, Inc.</FONT><BR>
<FONT STYLE="font-size: 10pt">+1 (858) 800-3500</FONT><BR>
<FONT STYLE="font-size: 10pt"><U>IR@modular-medical.com</U></FONT></P>


    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex99_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99_1.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 1@"6 P$1  (1 0,1 ?_$ +    (# 0$! 0
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M=-5B>VM;*+RW$;9&DQY4=N3&<2]'>2%M.H(4E23F"",9&CIIIJJ),!Z&  P
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MN.I%4T(\#0/?@S/#D>*"QYBI9>G6WX=PMI.XY=PAVMT.VRUOR&ELH<%=!TI
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M9[+BVW4LKM9+?=DPV"[RUVJ7'F,AHIJA;.:4J!K0*02GT'"QDUUCS@I4Y.I
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..LQ-J-=N!=2N9*T[1_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
